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Introduction
A number of reports have documented the 
negative consequences of current prohibitionist 
drug control policies on health, human rights 
and development,1 and these are the subject 
of growing international attention.2 The past 
thirty years has also seen a growing number of 
studies on women’s participation in all levels 
of the drug trade. However, limited research 
currently exists on the particular impact of drug 
control on women. This briefing paper focuses 
on this gap.  
This briefing aims to highlight the effects of 
drug policy on women as producers, suppliers 
and consumers of drugs in order to inform and 
guide policy makers on practices that should 
be avoided, as well as highlight those policies 
which effectively incorporate and address 
women’s needs. This briefing also features 
‘snapshots’ from women and service providers 
working with women that are affected by drug 
policies. These snapshots explore the complex 
consequences that drug policies have on both 
individuals and services. Such snapshots also 
highlight examples of interventions that seek 
to address the negative consequences of drug 
control and provide positive support to women.
Box 1. A qualifying note about gendered language 
 
This briefing paper focuses on how drug policies particularly affect women. Gender and sex 
are sometimes conflated in policy documents when discussing issues that relate differently 
to men and women. A person’s sex is a biological construct, while a person’s gender is 
a social construct. Gender is not a static, binary concept. Transgendered, two-spirited, 
transsexual, transitioning people, among others, may identify as the gender opposite of their 
sex, or may identify beyond the realm of either a ‘man’ or a ‘woman’. For the conceptual 
purposes of this paper, ‘women’ refer to people who self-identify as such, regardless of their 
biological sex.
2The international framework
Security, development and human rights 
have been identified by the Charter of the 
United Nations (UN) as the key policy ‘pillars’ 
of global governance systems.3 These pillars 
are enshrined in high level agreements as 
constituting the building blocks for international 
well-being and security.4 Women’s rights 
are specifically protected in a number of 
key international documents, including the 
Convention on the Elimination of Discrimination 
Against Women (CEDAW) and the 1995 Beijing 
Declaration, which aims to promote peace, 
development and equality for all women.5 
However, despite the increasing amount of 
information available on women’s involvement 
in drug production, traffic and consumption, 
UN bodies have not generally explored the 
various roles played by women in the drug 
trade.6 The international drug control system 
is based upon the 1961 Single Convention 
on Narcotic Drugs, the 1971 UN Convention 
on Psychotropic Substances and the 1988 
Convention against the Illicit Traffic in Narcotic 
Drugs and Psychotropic Substances. For the 
past 50 years, the governments have pursued 
tough law enforcement and prohibition-based 
policies which have led to a number of negative 
impacts particularly on health and well-being. 
This is despite the recognition in the preamble to 
the 1961 Convention of the need to uphold the 
‘health and welfare of mankind’. The Commission 
on Narcotic Drugs (CND), the UN’s drug control 
policy making body, describes drug dependence 
as an ‘evil’,7 while the International Narcotics 
Control Board (INCB), the UN agency in charge 
of monitoring the implementation of the UN 
drug conventions, encourages governments to 
adopt a strict interpretation of the conventions 
that prioritises a strongly punitive approach. 
The INCB often offers guidance on the UN 
drug control conventions without due regard 
to other international health, development and 
human rights obligations.8 Gender issues are no 
exception to this situation, and issues related to 
drugs and women have largely been ignored by 
UN drug control agencies and their policies. 
The situation has started to evolve over the past 
few years, with the CND starting to acknowledge 
the importance of women’s rights in drug policy. 
In Resolution 55/5 “Promoting strategies and 
measures addressing specific needs of women 
in the context of comprehensive and integrated 
drug demand reduction programmes and 
strategies”9 for example, the CND recognises 
CEDAW and the Beijing Declaration, and calls 
on UN member states to adopt drug control 
measures that respond to the needs of women. 
CND Resolution 52/1 “Promoting international 
cooperation in addressing the involvement of 
women and girls in drug trafficking, especially 
as couriers”10 also highlights key issues related 
to women’s involvement in the international 
drug trade. The resolution mentions the need 
for more evidence-based research on women’s 
involvement in the drug trade, and urges more 
education to reduce women’s participation 
in drug-related crime.11 However, although 
this resolution is a step towards incorporating 
gender issues into the drug policy agenda, 
the focus remains exclusively on the harms of 
women’s involvement in the drug trade, while 
ignoring the harms that can also be caused by 
drug control strategies on women.12 
The United Nations Entity for Gender Equality 
and the Empowerment of Women (UN Women), 
created in July 2010 by the UN General 
Assembly, stated explicitly that governments 
not only have the duty to pass laws that are 
aimed towards protecting women, but that the 
state should also take responsibility for laws that 
may have unintended consequences of harm.13 
It is therefore necessary to study women’s 
involvement in the drug trade and analyse the 
effectiveness of drug control strategies and their 
consequences, both positive and negative. Such 
research will constitute the basis for a potential 
review of harmful policies to ensure that the 
rights of women are protected effectively by 
national policies. 
3Women’s participation in the 
drug trade
 
Women are engaged at all levels of the global drug 
trade. This section intends to analyse the diverse 
roles that women play in the illicit production, 
trafficking and consumption of controlled drugs. 
Women’s involvement in drug production
Women play an important role in poppy 
cultivation in drug producing countries such as 
Afghanistan, Pakistan, Myanmar and Lao PDR,14 
and in coca production in the Andean region. 
Opium and coca cultivation can offer women 
the chance to earn money, and at times assume 
the role of the primary financial supplier for 
their family. However, while cultivation of crops 
destined for the illicit drug market may provide a 
degree of independence for some women, it can 
also lead to more demanding workloads. Women 
are often expected to continue performing their 
traditional duties; many are still expected to 
remain in charge of livestock, grain processing, 
dairy production and the management of fruit 
and poultry.15 As a result, time spent working 
in the fields can prevent women from passing 
on skills, such as tailoring and embroidery, to 
their children, or look for less traditional types 
of work. Their involvement in this part of the 
drug economy can therefore have certain 
ramifications in terms of intergenerational 
development and skill transfer. In addition, while 
it has been acknowledged that involvement in 
drug production can lead to increased economic 
independence and greater power, the majority 
of the time no significant redistribution of power 
occurs with the involvement of women in the 
global drug economy.16 Therefore, the power 
structures that tend to undermine women’s 
social and economic role remain the same. 
Women’s involvement in drug trafficking
Resolution 52/1 of the CND estimates that 
20 per cent of drug traffickers are women, 
based upon drug seizure reports,17 although 
comprehensive statistics on the rates of female 
drug smugglers worldwide are unavailable.18 
However, available estimates show that women’s 
participation in drug trafficking has increased 
significantly in recent years.19 In Mexico, for 
example, the importance of women’s roles in the 
trade continues to grow. The number of women 
imprisoned for federal crimes in the country has 
increased by 400 per cent since 2007, making 
the female prison population over 10,000. This 
spike has been partly attributed to the increased 
involvement of women in the drug trade.20 Many 
of these women are young – for instance, the 
majority of the 160 women incarcerated at El 
Cereso, a Mexican prison located in Ciudad 
Juares, are between 18 and 26 years old.21 
The main drivers for increased involvement of 
women in trafficking include economic hardship, 
an absence of well-paid job opportunities and 
the desire to provide adequate housing and 
education for their children.22 
Other possible reasons for the increase of 
women participating in drug trafficking include 
the reality that women sometimes play on 
traditional conceptions of femininity in order 
to avoid being suspected as participating in 
criminal activity.23 Furthermore, women will 
often accept lower payment than men for similar 
work. An example is Kyrgyzstan, where there has 
recently been an increase from 5 per cent to 12 
per cent of women involved in drug trafficking, 
partly because women are compelled to accept 
lower rates of pay than men.24
Based on the current research available, only 
a small number of women reach a level of 
socio-economic independence through their 
involvement in the drug trade. In his study of the 
US-Mexico border, Campbell argues that of all 
the women involved in drug trafficking, it is the 
women at the highest level of drug organisations 
who manage to achieve a level of ‘empowerment’. 
Enedina Arellano Felix, believed to run the Tijuana 
cartel, is the highest-profile female cartel leader 
in Mexico.25 Sandra Ávila Beltrán, dubbed the 
‘Queen of the Pacific’, was another high-profile 
4cartel leader who was arrested in 2007 for money 
laundering and drug trafficking.26 Campbell’s 
study reviews female drug lords, women engaged 
at the middle level, low-level drug couriers and 
women who have little involvement but maintain a 
connection to the trade through their relationships 
with men. While this study is temporarily and 
contextually specific, Campbell argues that it is 
applicable to women involved in drug smuggling 
‘cross culturally, despite differences in specific 
political and social conditions’.27 Female drug 
lords contradict the view of women in the drug 
world as that of ‘passive, appendages of male 
traficantes’. 28 While very few women reach this 
level of ‘queen pin’, the fact that they exist at all 
may mean that they may serve as symbols of 
female power for other women in the drug trade.29 
In this context, it is essential to distinguish 
between drug couriers (low-level individuals 
who usually transport drugs across the border 
out of poverty and economic necessity) and 
drug traffickers (individuals at the higher level 
of the trade chain, who have both organisational 
and economic power which allows them to 
make considerable profits out of the drug 
trade). Women are mostly involved as low-level 
drug couriers. They sometimes conceal drugs 
internally, ‘in brassieres, in other clothing items, 
in faked pregnancies or surgically implanted 
in the buttocks’. 30 Single mothers sometimes 
become involved in transporting drugs across 
the border due to the feminisation of inequality 
and poverty. However, it is simultaneously a way 
for women involved in the drug trade to achieve 
a certain level of economic independence from 
a male partner.31 In their analysis of fifteen 
different studies on women’s involvement 
in the drug economy in various parts of the 
United States, researchers Maher and Hudson 
found that although the studies varied spatially, 
temporally and in terms of methods used, the 
majority demonstrated the hierarchical nature 
of the drug economy, with women holding 
subordinate or peripheral roles.32 
It is also important to consider people involved 
in drug trafficking in order to finance their drug 
Box 2. The linkages between drug dependence and drug dealing
The snapshot below was written by a British woman who explains her experience of drug 
dealing and drug dependence. Her testimony illustrates how people can get caught up in 
different aspects of the drug trade. 
‘I sold drugs from around the age of 20, via boyfriends who were selling at the time, until the age 
of about 25. At the age of 22, I was smoking weed heavily and was approached by a local dealer 
who asked if I wished to ’tick’ (receive the drugs upfront and pay for them once they had been sold) 
a large amount of weed. I readily agreed as I knew a lot of people who regularly smoked and this 
also meant that I would end up smoking for free. My ‘business’ started off relatively small and I was 
selling mainly to my friends and family members. I felt that this was quite safe as these people would 
often come and visit me anyway, so this would not arouse suspicion from my neighbours. However, 
the business rapidly escalated and over the next few years my house became extremely busy.
However, being unemployed and socialising day in, day out with some of these people led me 
towards other drugs and I started to use cocaine. I was then approached by the dealer I was buying 
this from, who was impressed by the way in which I ran my weed business and offered to supply me 
with cocaine to sell. I quickly added this to my existing business. Unfortunately, my use of cocaine 
also quickly escalated due to there being a constant supply at my fingertips. […] In the end I was just 
selling drugs (from a variety of different people by this point) in order to fund my habit’.
5dependence. As is the case with poverty, drug 
dependence should also be considered as a 
mitigating factor in the imposition of penalties 
against drug traffickers, and include a health 
component, such as the possibility to attend 
evidence-based drug dependence treatment 
programmes. The snapshot below exemplifies the 
linkages between trafficking and drug dependence. 
Women’s involvement in drug 
consumption
While precise data on the number of women 
who use drugs is rarely available, it is estimated 
that women represent 40 per cent of people 
who use drugs in some parts of Europe and the 
United States, 20 per cent in Eastern Europe, 
Central Asia and Latin American, and between 
17 and 40 per cent in certain provinces in China 
and 10 per cent in other parts of Asia.33 Recent 
years have seen a rapid increase in the number 
of women who use drugs, particularly in Asia 
and Eastern Europe.34 
It should be noted that most women who use 
drugs consume these substances occasionally, 
and/or without problems. Therefore, many 
women who use drugs do not experience 
some of the problems that will be discussed 
below. Those that are most affected by drug 
dependence, drug-related harms and the 
negative consequences of drug control (see 
next section of the briefing) are usually women 
who use drugs in difficult socio-economic 
Box 3. The experience of a woman who uses drugs in Ukraine 
In Ukraine, it is estimated that 290,000 people (that is, 0.9 per cent of the population) 
use drugs. Of these, approximately 87,000 (30 per cent) are women. Out of the 
165,006 people who use drugs registered in police databases, only 47 per cent of 
them (77,840) are registered in hospitals. In October 2010, the criminal liability for 
possessing small amounts of drugs was restored, which led to a reduction in clients 
accessing needle and syringe programmes, and an increase of 15 per cent of arrests 
for drug possession in the first quarter of 2011.
‘“Drugs saved me from suicide”, said my female friend from Russia, as we sat in a cafe at the 
Vienna Conference on AIDS. I am also one of those women who began using drugs to get rid 
of the emotional pain of rape. Since then, 26 years have passed. During that time I endured 
more pain and humiliation following calls for help at the hospital.
I was always interested in the question: “When doctors offer a new method of treatment for 
drug addiction why is nobody watching what happens to a person afterwards?” It is harassment 
and humiliation, legitimised by one stereotype: she’s a “drug addict”.
In 1995, I did  a “clean blood” procedure, so-called “Hemosorption”. A three day course costs 
the same as two months’ average salaries in Ukraine. Three days later, I was discharged from 
the intensive care unit with clean blood and in abstinence from drugs. The pain ripped through 
my body, and a desire to inject drugs tore through my brain. I found drugs very quickly, and 
received the first result of ‘treatment’ – an overdose.
That night in the hospital ward; tied to a bed with sheets, coming off of the anaesthesia after an 
unplanned operation. I was in a lot of pain after surgery, and from withdrawal. My whole body 
was twisted. Waiting for my husband, he will bring heroin. The doctors and nurses, of course, 
immediately guessed that I was an addict. I asked them to give me pain medication, begging. 
They replied: “Be patient. You are to blame”’.
6environments, living in situations of poverty and 
are at the margins of society.
Women experience more negative 
consequences from drug use than their male 
counterparts.35  Although many women use 
drugs without experiencing any problems, 
many other women use drugs in environments 
of economic deprivation, and their use is often 
impacted by class and gender inequalities.36 
In addition, although drug use is generally 
stigmatised, women’s use carries a double 
stigma, as it is usually seen as contravening the 
natural roles of women in society as ‘mothers, 
the anchors of their families, and caretakers’.37 
The stigma of drug use is also compounded 
with gender discrimination (see Box 3).
Women are also reportedly more likely to provide 
sex in exchange for housing, protection, drugs 
and/or sustenance. They also tend to experience 
violence from sexual partners and may have 
difficulty insisting that male sexual partners 
use condoms, making them more vulnerable 
to HIV and other sexually transmitted infections 
(STIs).38 In addition, several studies have found 
connections between intimate partner violence 
or sexual violence and the illicit use of controlled 
drugs, in particular marijuana and crack use.39 
Researchers have underlined the need for further 
research in this area.40 Often, drug prevention and 
law enforcement interventions that have been 
developed around the world do not take due 
account of all of these connections.41
Women tend to share injecting equipment more 
frequently than men. Further, when injecting 
with men, women are more likely to be ‘last on 
the needle’, which has attendant implications 
concerning the risk of transmission of HIV 
and other blood-borne viruses from the use 
Box 4. Raising the voice, and promoting the rights, of women who use drugs
There are two main global networks that seek to represent women who use drugs and protect their 
basic human rights – the International Network of Women who Use Drugs (INWUD) and the Women 
and Harm Reduction International Network (WHRIN).
INWUD is a global network that represents women who use drugs in international agencies and with 
those that undertake international development work. It collaborates with other agencies to ‘voice’ 
the issues affecting women who use drugs. As well, INWUD provides women with a safe space 
(through a list serve) where they can share ideas and challenges they face when seeking support 
and promote women who use drugs as equal partners and contributors in all aspects of drugs theory 
and practice, including drug policy, drug law reform and harm reduction development. INWUD also 
conducts advocacy activities in order to impact on policy and practice.
WHRIN is a global platform that aims to reduce the harms associated with drug use by women 
and to develop an enabling environment for the implementation and expansion of harm reduction 
resources for women. It also seeks to facilitate access to high-quality resources, including educational 
materials, to assist women who use drugs and the people who work with them to improve access 
to gender-sensitive harm reduction services. Finally, WHRIN advocates for national, regional and 
international bodies to adopt and implement policies and programmes that promote and support 
harm reduction interventions that are adapted to the needs of women and girls.46 
Because of their unique view and expertise, these two networks are a crucial source of information 
and should be involved in the review, design and implementation of drug policies that affect women 
who use drugs.47
7of contaminated equipment. Women are also 
more likely to be injected by someone else, and 
to continue to be injected by a partner for long 
periods post-initiation, increasing the risk of 
transmission of blood-borne viruses.42
Studies across nine European countries found 
that HIV prevalence was over 50 per cent higher 
among women who inject drugs than their 
male counterparts. This figure is most likely 
much higher in countries where harm reduction 
programmes are not well developed. One study 
found that in Mombasa, Kenya, HIV infection 
was prevalent among 50 per cent of all people 
who inject drugs, but this figure reached 85 per 
cent among women who inject drugs.43 
The recent report, ‘HIV and the law: Risks, rights 
& health’, by the Global Commission on HIV and 
the Law concludes that the criminalisation of 
drug use and sex work in many countries are 
major drivers of the HIV epidemic on a global 
scale.44 There is a pressing challenge to develop 
ways to protect women who use drugs from HIV 
transmission.45
Recently, various international networks were 
created to promote the rights of women who 
use drugs and challenge the impact that some 
policies could have on them. These notably 
include the International Network of Women 
who Use Drugs and the Women and Harm 
Reduction International Network (see Box 4). 
These networks are instrumental to document, 
analyse and seek solutions to the numerous 
challenges faced by women who use drugs.
 
The Impact of drug policies on 
women 
 
There is a general assumption in the literature 
reviewed that drug laws affect women 
predominantly as consumers of drugs. While 
this is indubitably true, there is a significant 
lack of exploration of the impact of drug control 
on women involved in other sectors of the 
international drug market.48 Although a growing 
amount of studies consider women’s roles as 
producers, consumers and traffickers,49 much 
research focuses on women who use drugs, 
rather than on analyses of how drug policies 
impact women who are engaged in all aspects of 
the drug trade.50 This section seeks to address 
this particular point.
Exacerbation of poverty 
The involvement of people, and sometimes 
entire families, in drug production, trafficking 
and/or consumption often results from a 
variety of coercive forces ‘...often driven or even 
necessitated by poverty and social neglect’.51 
These drivers are usually overlooked and often 
worsened by contemporary drug policies that 
emphasise eradication and prohibition.52 Our 
analysis shows that some aspects of drug 
control are particularly harmful to women. 
Current policies have detrimental consequences 
for people who are dependent on drug crops 
for survival. Although drug crops generate 
an amount of household income in poppy 
production areas, there is scant evidence 
to suggest that drug production can lead to 
sustainable economic and social development.53 
In an illicit, unregulated market, appropriate 
mechanisms do not exist to ensure that growers 
receive a fair price for the goods they produce. 
A regulated market might be able to ensure that 
subsistence farmers are properly remunerated. 
In Vietnam, for example, areas that cultivate 
poppy have the lowest household income in 
the country. 54 In Pakistan, the average income 
for those households producing drugs was 
half of the national average.55 Crop eradication 
campaigns often lead to the destruction of both 
crops destined for the drug market and food 
crops (and therefore of farmers’ only means of 
subsistence), forcing entire groups to relocate 
to more isolated areas. Prohibition-led drug 
policies have specific negative impacts on 
women and girls. In conflict areas, when men 
are caught between war factions, women are 
often left with little choice other than to re-plant 
8drug crops for their and their children’s survival. 
In Afghanistan, law enforcement-led approaches 
have put poppy-field eradication at the centre 
of counternarcotics policy.56 Counternarcotics, 
counterterrorism and counter-insurgency 
policies have detrimental consequences on 
subsistence farmers. They can also have 
particularly negative effects on girls, child drug 
users and families. For example, some farmers 
had reportedly resorted to selling their daughters 
in order to pay off their opium debts.57 
Similarly, women involved in drug trafficking 
mainly do so out of economic necessity. In 
many countries, laws regarding drug trafficking 
do not differentiate between the different levels 
of involvement and power, resulting in low-level 
drug couriers serving disproportionate penalties, 
sometimes involving years of imprisonment.58 
This leads to an exacerbation of poverty as 
those individuals with a criminal record may be 
denied access to educational or employment 
opportunities, leaving them with little choice 
but to engage again in criminal activities. Both 
men and women become drug couriers and 
may be affected by disproportionate penalties 
for their offence. However, women are often 
those in charge of the household and children. 
The incarceration of women for lengthy periods 
of time may result in children having no other 
choice but to accompany their mother to 
jail or end up in the streets, often selling or 
consuming drugs.59 Poverty has now started to 
be considered in some laws and/or sentencing 
guidelines as a mitigating factor in courts. This 
is the case, for example, in the UK, where a 
review of the country’s sentencing guidelines 
recommended a re-calibration of approaches to 
sentencing for drug offences.60 
Drug dependence is also often related to 
situations of poverty. Evidence from around 
the world shows that drug dependence 
remains strongly concentrated among the 
most marginalised groups of society, and is 
associated with harsh living conditions and 
associated trauma.61 However, it is necessary 
to point out that not all drug use is driven by 
poverty. Indeed, as mentioned previously, many 
people use drugs occasionally and/or without 
problems. Drug use is also driven by motivations 
of pleasure, and in many circumstances do not 
experience any negative consequence to the 
user’s health and social well-being. Those most 
affected by the consequences badly designed 
drug control policies are those who use drugs in 
situations of poverty and social deprivation that 
often have a strong connection with dependent 
use. As will be discussed below, many structural, 
cultural and ideological factors make women 
particularly vulnerable to health and social 
problems associated with drug use. 
Inadequate provision of, and 
discrimination in accessing, health 
services
Social and biological factors often result in 
women’s experiences with drugs different to 
that of their male counterparts.62 Nevertheless, 
drug policies and programmes rarely take 
account of these differences. This can be 
illustrated, for example, by the lack of provision 
of gender-sensitive harm reduction services. 
Much improvement has taken place to provide 
harm reduction services to people who use 
drugs across the world, but many countries do 
not provide any services or only provide them 
on a small scale. In addition, although there is 
evidence to show that providing harm reduction 
services that specifically target women 
improves intervention outcomes, gender-
sensitive interventions have not been integrated 
into harm reduction services on a global level.63 
This translates into a lack of provision of sexual 
and reproductive health resources in addition to 
HIV prevention, treatment and care specifically 
tailored to the needs of women who use drugs. 
There is also a chance that women will suffer 
from breaches of confidentiality in relation to 
their HIV status and drug use. This can result 
in harassment, violence and family conflicts 
or crises.64 In addition, many services do not 
provide child-care facilities, or do not accept 
pregnant women or women with children.65 
For women who have children, this acts as a 
9significant deterrent to accessing services. 
Other services may be located in areas that are 
unsafe for women to travel alone or are located 
in hard to reach places. Inflexible opening hours 
can also mean that those women with domestic 
responsibilities have difficulty accessing the 
services, and there is often a lack of outreach 
services which could extend healthcare to 
potentially hidden populations of women.66 
These issues, coupled with the criminalisation 
of drug use, discourage many women from 
accessing health, harm reduction and drug 
dependence treatment services.67 
Women who use drugs are sometimes 
characterised as ‘the lowest of the low’ by both 
men and women involved in the drug trade.68 
Stigma, abuse and violence towards women 
who use drugs may be compounded by ideas 
about what constitutes acceptable behaviour 
for women. This stigma often constitutes 
another barrier for women from accessing harm 
reduction services, HIV prevention, care and 
treatment, drug dependence treatment, sexual 
and reproductive health care, as well as other 
medical services.69 Some countries have sought 
to address this issue by providing gender-
sensitive services for women who use drugs 
(see Box 5).
Drug use and sex work are often intertwined,77 
and the harms associated with sex work and 
drug dependency can be mutually reinforcing. 
Research studies have found that sex workers 
Box 5. Reducing stigma in Iran, Afghanistan and India with gender-sensitive 
programmes
Stigma and discrimination were important factors information the lives of women who use 
drugs in Iran.70 The majority of women dependent on drugs have never received any help for 
their drug use.71 In 2007, a methadone clinic specifically designed for women was established 
in Tehran. A review conducted by the clinic found that there was a significant uptake of services 
after it opened in 2007, with almost 100 women registered during the first year of operation. 
Clients started engaging in consultations with various healthcare professionals, including a 
psychologist, a doctor, a midwife and a social worker, and consider the clinic to be a supportive 
environment, offering essential services.72 
Centres for women who use drugs have also been set up in Afghanistan, another country where 
women’s drug use is rarely mentioned due to stigma. Laila Haidari, an Afghan woman, sought 
to break this stigma when she founded two centres for women who use drugs in Kabul;73 one 
for men and one for women and children.74 She also opened a restaurant, which she hopes will 
be staffed by those who went to the shelters – giving them a chance to learn new skills, rebuild 
their lives and reduce the stigma attached to drug use, whilst helping her operate a business.75
Chanura Kol in Manipur, India is another example of a service which was established to offer 
care and support services specifically for women who inject drugs. Many women who inject 
drugs in Manipur are HIV positive and require general and emergency care. The aim of Chanura 
Kol is to decrease the transmission of HIV and drug relapse amongst women who inject drugs. 
The project is set to run for three years (2010-2013) and seeks to reach 700 women who use 
drugs and provide them with care and support. A major element of the project is the provision 
of income generation support to prevent women relapsing after they have stopped using drugs. 
Chanura Kol has also filed cases on behalf of sex workers who have been the victims of violence 
perpetrated by clients, police officers or pimps. The services are offered in a non-discriminatory 
way free of stigma and moral judgement, based on the principles of harm reduction.76
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who are believed to be using drugs can be 
prevented from working in safer environments, 
such as co-operative sex work establishments. 
This can mean that open, street-based and 
relatively dangerous markets become the only 
ones available to sex workers who use drugs.78 
Sex workers can also face restricted access to 
harm reduction services, and usually face stigma 
and discrimination with health care services.79 
Women who use drugs and engage in sex work 
therefore often face dual discrimination and 
vulnerability. As mentioned previously, women 
are often at a higher risk of contracting HIV, partly 
due to the criminalisation of sex work and drug 
use. It is estimated globally that sex workers are 
about eight times more likely to be infected with 
HIV than other women.80 In developing countries, 
this rate is estimated to be fourteen times higher 
than women not engaged in sex work.81 Such a 
high risk of infection has implications for the sex 
workers themselves, their sexual partners, their 
clients and the clients’ partners.82
Incarcerated women who use drugs usually 
have even more difficulty accessing life-saving 
medical services. In the USA, imprisoned 
women have higher rates of HIV, hepatitis C and 
serious mental illnesses than among the general 
population, but may be denied basic medical 
care.83 An EMCDDA report also found that 
because there are significantly less imprisoned 
women than men, there is a lack of specialised 
care services for women.84 As a result of the lack 
of evidence-based drug dependence treatment 
services, self-harm and depression are reported 
amongst women who are withdrawing from 
drugs.85 In Europe, for example, it is estimated 
that up to 80 per cent of women in prison have 
a diagnosable mental health problem, often 
coupled with drug use. Although approximately 
4 per cent of prisoners in Europe are women, 
around 50 per cent of all self-harm incidents in 
prison are carried out by women. Death rates 
on discharge are also substantially higher for 
women than for men.86
Ethnicity, discrimination and drug control
Those who suffer most from prohibition-led 
approaches are generally ethnic minorities, 
economically vulnerable people and other 
marginalised groups (see Box 6).87 Female 
drug couriers in Ecuador, for example, are often 
motivated by poverty and constitute a large 
Box 6. Racial discrimination in drug law enforcement in the UK
In the snapshot below, a black British woman discusses her experience of being 
regularly stopped and searched for drugs, highlighting how the current practice can 
facilitate a lack of confidence and trust towards the police.
‘On some of the occasions when the police didn’t make me feel too uncomfortable, it was like 
“okay its nothing, cool breeze”. I could then go along on my daily route and it was nothing, but 
on most of the occasions I would just go home and stay in my house and be like “well I don’t 
really wanna go out anymore” because I haven’t done anything so what I am being stopped 
and searched for on so many occasions. Once or twice is fine, but on so many occasions it’s a 
bit of a deterrent to go out […]. 
To say I have a good relationship or a good eye view of the police, not really. My views are 
pretty negative. As far as I see it they are the police and I am me. They have got to do their job, 
so stop and search and do your job […]. I think it would take a lot for me to go to the police. If 
I felt like I could handle it myself without committing a crime then I wouldn’t approach them’.
11
proportion of the prison population.88  Similarly, 
in Canada and the USA, ethnic minorities are 
more likely to be incarcerated for drug related 
offenses than their Caucasian counterpart, 
especially amongst Native American, aboriginal 
and First Nations’ people.89 In the USA, African 
American women are seven times more likely 
to be incarcerated than Caucasian women and 
almost 70 per cent of those imprisoned were 
found to be single parents responsible for young 
children prior to being put in prison.90 Policies are 
often detached from the socio-economic reality 
of women who are living in poverty.91 Current 
drug policies and their implementation seem 
to exacerbate discrimination based on class 
and race.92 In the USA, welfare acts such as the 
Temporary Assistance for Needy Families (TANF) 
prevent people convicted with state or federal 
offenses from being eligible for food stamps or 
any state form of cash assistance.93 Such policies 
disproportionately affects the groups of women 
most criminalised for their drug-related activities 
(i.e. African American women), and impacts their 
ability to access health and social services, find 
and maintain adequate housing and employment, 
and break out of poverty-ridden situations.
There is a lack of knowledge about the ways 
in which interactions between gender and 
ethnicity shape experiences for men and women 
within specific drug markets and the broader 
drug economy.94 The categories of gender, race 
and class are just as relevant to power relations 
and social stratification systems as are evident 
in the formal economy.95  The complexity of 
such dynamics is glaringly absent from current 
drug policies. 
Increased numbers of women 
incarcerated for drug offences
As a result of the increased involvement of 
women in all aspects of the drug trade and of the 
punitive nature of drug control in most regions 
of the world, women are more represented in 
criminal justice systems and prison populations 
worldwide than ever before. 
In Mexico, the number of women in prison 
increased by 592 per cent between 1977 and 
2001, mainly because of mandatory minimum 
sentencing laws in place since the early 1970s. 
This makes women the fastest-growing prison 
population across the nation for drug offences.96 
Across Europe and Central Asia, there are 
approximately 31,000 women in prison for 
drug offences – representing 28 per cent of the 
female prison population in this region.97 
 
Women in penal institutions worldwide are 
generally young, have a low level of education 
and have dependent children.98 A study 
undertaken by the European Commission 
found that many incarcerated women in 
Europe did not have financial security prior to 
incarceration, had never been employed or had 
held low-paid jobs with no job security, did not 
have secure accommodation, had a low level of 
education, were foreign or belonged to ethnic 
minorities and had been victims of physical 
and/or sexual violence.99 In the USA, more 
women are convicted for non-violent drug-
related crimes than for any other as a result of 
mandatory minimum sentencing laws. Although 
men still greatly outnumber women in arrests 
for drug-related crimes, women now comprise 
the fastest increasing prison population 
nationwide for drug offences.100 It is estimated 
that between 1986 and 1999, punitive drug 
policies have resulted in an increase in the 
female prison population in the USA by up to 
888 per cent.101
Incarcerated women who use drugs often 
face deteriorations in their general health and 
social ties during incarceration and as such 
face a very difficult period of reintegration into 
society following release.102 In the USA, Russia 
and Georgia, for example, people who have 
been convicted for drug offenses or who are 
identified as drug users risk being denied public 
housing and other benefits, risk losing custody 
of their children and face discrimination from 
employers, courts, doctors and educational 
institutions.103  
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In 1999, the UN Special Rapporteur on Violence 
against Women stated that many women who 
are incarcerated for drug-related offences could 
be better served by community-based welfare 
and social support systems. However, this is 
yet to happen in many parts of the world.104 
There is a pressing need for a removal of harsh 
drug laws and the provision of appropriate 
services for children while their mothers, who 
are often their primary carers, are in prison. 
For instance, Argentina has recently reviewed 
the national regime of drug sanctions. In 2012, 
a draft piece of legislation was introduced in 
Parliament proposing to decriminalise drug 
possession for personal use and to lower the 
minimum penalty range for smuggling of drugs. 
This was justified by the fact that many people 
employed by criminal organisations to transport 
small amounts of drugs were women from 
disadvantaged backgrounds, who are often 
coerced into such activities.105
Law enforcement, imprisonment and 
parenting 
Families and motherhood are dramatically 
reconfigured and disrupted by policies based on 
harsh punishment and imprisonment for women 
involved in the drug trade.106 The majority of the 
time, women are incarcerated for non-violent 
offences and come from economically and 
socially marginalised backgrounds, with a main 
driver of crime being poverty. Many of these 
women are mothers. In Ecuador, for example, 
women (many of whom have children) are 
particularly vulnerable towards being engaged 
in micro-trafficking because of poverty and 
lack of any employment opportunity in the legal 
economy. Once imprisoned, the chances for 
women to make positive changes in their lives 
and move away from the drug trade become 
even more unattainable.107 
A recent study in the USA found that arresting, 
detaining, prosecuting and taking other legal 
actions against pregnant women who use drugs 
draws attention away from existing inadequacies 
in health care, the absence of policies to 
support pregnant women, the lack of social 
services for children and the failings of punitive 
drug policies. The study also found that current 
measures undertaken in the criminal justice 
system and family and drug courts that attempt 
to ‘protect the foetus’ in fact undermine foetal 
and maternal health and are not conducive to 
producing effective strategies for addressing the 
needs of pregnant women who use drugs and 
their families.108 No state in the USA specifically 
criminalises drug use during pregnancy, but 
prosecutors have made attempts to draw upon 
criminal laws currently in existence in order to 
attack prenatal substance use. Currently, fifteen 
states regard drug use during pregnancy as 
child abuse, and in three states (Wisconsin, 
South Dakota and Minnesota) it is grounds 
for civil commitment.109 Although there are 
programmes for pregnant women to receive 
drug dependence treatment, only four states 
prohibit publicly funded treatment programmes 
from discriminating against pregnant women.110 
All leading US medical organisations that 
have studied drug use during pregnancy 
have concluded that this is a health issue that 
should be addressed through education and 
community-based family treatment rather than 
through the criminal justice system.111 
Pregnant women who use drugs also face 
considerable stigma and discrimination.112 
Sterilisation campaigns further compound this 
stigma and are a violation of human rights. 
Project Prevention, an organisation that offers 
a one-off payment to women who use drugs 
to be sterilised was started in the USA and has 
since branched out to the UK. This programme 
offers women who use drugs payment for long-
term contraception (as the British Medical 
Association ethical requirements prevented 
the organisation from offering money for 
sterilisation).113 Recently, the organisation began 
operations in Kenya, where the programme 
pays women living with HIV to accept long-term 
contraception.114 The project has been strongly 
criticised as taking an extremely stigmatising 
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and demeaning approach to women who use 
drugs and to women living with HIV, and for not 
allowing women to make informed decisions 
about their reproductive health.115 Furthermore, 
providing monetary incentives for women to 
accept sterilisation or long-term contraception 
has been condemned as being coercive and a 
violation of reproductive choices and rights.116 
In Norway, pregnant women who use drugs may 
lose the right to personal freedom and remain 
under the control of ward staff until they give 
birth or decide to terminate the pregnancy.117 
Norway is the only country where social 
workers have the right to incarcerate pregnant 
women who are dependent on drugs.118 A 
combination of stigma and pressure to have an 
abortion can mean that women who use drugs 
have limited access to prenatal care. One of the 
many negative effects of such a policy is the 
lack of access to services designed to prevent 
vertical transmission of HIV amongst pregnant 
women who inject drugs living with HIV, as 
well as general healthcare services to ensure 
that pregnancy and childbirth occur in healthy 
conditions.119
Many women are also disproportionately 
affected by the removal of their children from 
their custody in many countries.120 It should be 
recognised that drug use does not by definition 
make a woman unfit to care for a child. Indeed, 
while in some cases parental drug use is 
associated with child mistreatment, drug use by 
parents does not necessarily equate with abuse 
or neglect of their children.121 Research has 
shown that families in which drug or alcohol use 
is present are more likely to be reported and 
re-reported to child protection services, and 
Box 7. Breaking the Cycle – Parenting and drug use in Canada
Amidst the austerity measures that have resulted in budget cuts from social and health services, 
a number of programmes are still thriving to assist pregnant and early parenting women who 
are dealing with drug and alcohol use issues. Breaking the Cycle is a Toronto-based initiative 
that aims to address the needs of their clients through a single access site, as well as providing 
a number of outreach services for pregnant and early parenting women with children up to six 
years old. Founded in 1995, Breaking the Cycle provides a range of services for their clients, 
including access to drug dependence treatment, pre- and post-natal care, parenting courses, 
nutrition and clothing programmes, and a wide range of counselling services. Breaking the 
Cycle aims to decrease isolation for women and to encourage them to access services by 
collaborating with other community-based programmes that can refer women to the various 
agencies and services, including assistance for clients who have unstable housing or are 
homeless. 
Similar centres such as Sheway in Vancouver and Maxxine Wright Place Project in the Fraser 
Valley, British Colombia, and New Choices in Edmonton, Alberta, offer comprehensive, non-
judgmental care for women in a safe and supportive environment. Such centres continue to 
slowly develop to a limited capacity throughout Canada. Such initiatives are continuing to 
slowly grow across the country, as is the case with the HerWay Home programme in Victoria, 
British Colombia. HerWay Home opened the first phase of their centre in late 2012, and offers 
basic health and social services, with the aim of expanding to respond to childcare and housing 
needs. These programmes are therefore moving beyond the traditional and narrow view of 
drug dependence treatment services, and embrace a holistic notion of caring for pregnant and 
early parenting for women who use drugs through respect and empowerment.126
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are more likely to have children removed from 
their custody than those families with similar 
characteristics but no substance use. A recent 
study from the Australian Child Protection and 
Mothers in Substance Abuse Treatment found 
that the focus of policy and practice should be 
on interventions that address the mental health 
problems of mothers who use and improve their 
social support networks.122 This is supported by 
research in Canada, a country where children 
can be removed from families on the basis of 
parental drug use.123 Rather than channelling 
money into providing support for families where 
there is drug use (such as affordable child care, 
safe housing and health and social services), 
money is spent on foster and group homes. 
The lack of effort to provide supportive services 
where there is parental drug use is particularly 
evident in the case of aboriginal and First Nations’ 
families. Nor are there services provided for 
women who are dealing with the aftermath of 
having had their children removed from their 
custody. Studies in Canada have recognised 
that women’s drug use is often shaped by a 
variety of factors including poverty, physical 
abuse, punitive drug policies and inequalities 
in race, class, gender and sexuality.124 In Kenya, 
there are no specific policies in place to remove 
children from the custody of women who use 
drugs, but as per culture and tradition there are 
many instances when family and relatives can 
remove children from their drug using mothers. 
Often these children are mistreated and put to 
early exploitative employment. This practice 
clearly overlooks the health and wellbeing of 
the mother and the child under the guise of 
saving the child.125
Some programmes have been developed in a 
few countries to remedy the harmful effects of 
drug laws and their enforcement on parenting 
rights. This is the case, for instance, in Toronto, 
Canada, with the Breaking the Cycle programme 
(see Box 7). 
Abuse and violence by law enforcement 
officials
Since drug use remains criminalised and 
governments have often adopted a zero-
tolerance approach towards people involved in 
the drug trade, the latter often come in contact 
with law enforcement authorities, be it the 
police, prison employees or officials running 
labour camps for people who use drugs. As 
a result of the stigma specifically attached 
to women involved in the illicit drug market, 
practices of mistreatment, violence and sexual 
abuse are often reported. One study in Guanxi, 
China, found that guards at a forced labour 
camp used HIV testing data to determine which 
women they could have sex with without using 
a condom.127
In many countries, the criminalisation of drug 
possession has resulted in sexual exploitation 
of women by the police.128 An assessment 
in Eurasia in 2009 found that 13 per cent of 
female respondents in Georgia had been asked 
for sexual favours during arrest. In Azerbaijan, 
15 per cent of those participating in the 
assessment reported beatings by police, and 
7 per cent reported coerced sex or rape by 
police officers and in Kyrgyzstan, 40 per cent of 
respondents reported violence perpetrated by 
police officers.129 In Kazakhstan, it was reported 
that police arrive at locations where drugs are 
dealt and conduct body cavity searches. This 
often leads to demands for sexual favours in 
exchange for the return of drugs.130 
In El Inca, the largest women’s prison in Ecuador, 
male prison guards often demand that incarcerated 
women provide sexual favours in order to obtain 
access to services or other necessities. Until 
2007, guards were able to call for a full body 
search at any time and such searches, which 
included a vaginal search, were used as a form 
of punishment.131 While international documents 
such as the United Nations 2010 document Rules 
for the Treatment of Women Prisoners and Non-
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custodial Measures for Women Offenders, known 
as the ‘Bangkok Rules’, call for fair and equitable 
treatment of imprisoned women and condemn 
violence, such rules are not always enforced in 
practice.132
Police interference in health service provision 
can also discourage women who use drugs 
from accessing harm reduction and other health 
services. A 2008 study in St. Petersburg, Russia 
found that women who had been subject to 
police violence at a needle and syringe exchange 
bus a decade earlier were still apprehensive 
about accessing harm services.133
Conclusion and 
recommendations
It is clear that current drug policies that 
emphasise punishments and incarceration 
are not only ineffective but also have serious 
negative implications for women’s health, 
social and economic situations, and can result 
in violations of women’s rights. Not only are 
women affected, but so are their children and 
families, particularly in cases of incarceration. In 
order to ensure that gender-sensitive policies 
and programmes are adequately designed and 
implemented, it is necessary that: 
•	 Governments should conduct more 
research into the different ways women are 
involved in the drug trade and the potential 
harms that current drug policies can have 
on them. 
•	 Governments should promote drug policies 
and programmes that are evidence-based, 
respectful of human rights principles, 
gender-sensitive, and that emphasize 
health and social inclusion. 
•	 Governments should encourage the 
participation of those directly affected 
by drug policies in the design and 
implementation of drug policies.
•	 In the field of drug production, governments 
should promote alternative development 
programmes that integrate gender issues.
•	 In the field of drug trafficking, drug laws 
should make a clear distinction between 
high-level trafficking and minor level 
offences, such as couriering and low-
level dealing, and impose proportionate 
penalties that take into account socio-
economic factors.
•	 In the field of drug consumption, 
governments need to ensure that women 
who use drugs can access gender-sensitive 
harm reduction and drug dependence 
treatment services without fear of arrest or 
stigma and discrimination.
•	 At the international level, UN agencies 
should seek to promote better health, 
development and human rights practices 
that fully integrate gender issues as a key 
component of drug policy.
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